ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
sailnyssa
|
13K |
5.0M |
7 |
17/08/20 |
17/08/20 |
ASX - By Stock
|
13K
|
5.0M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
sailnyssa
|
13K |
5.0M |
42 |
16/08/20 |
16/08/20 |
ASX - By Stock
|
13K
|
5.0M
|
42
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
sailnyssa
|
13K |
5.0M |
1 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
13K
|
5.0M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
sailnyssa
|
13K |
5.0M |
42 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
13K
|
5.0M
|
42
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
sailnyssa
|
13K |
5.0M |
2 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
13K
|
5.0M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
sailnyssa
|
13K |
5.0M |
2 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
13K
|
5.0M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
sailnyssa
|
13K |
5.0M |
1 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
13K
|
5.0M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ryoncil: ODAC/FDA Meeting Discussion
|
|
sailnyssa
|
2.0K |
693K |
3 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
2.0K
|
693K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ryoncil: ODAC/FDA Meeting Discussion
|
|
sailnyssa
|
2.0K |
693K |
2 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
2.0K
|
693K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ryoncil: ODAC/FDA Meeting Discussion
|
|
sailnyssa
|
2.0K |
693K |
8 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
2.0K
|
693K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ryoncil: ODAC/FDA Meeting Discussion
|
|
sailnyssa
|
2.0K |
693K |
2 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
2.0K
|
693K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ryoncil: ODAC/FDA Meeting Discussion
|
|
sailnyssa
|
2.0K |
693K |
2 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
2.0K
|
693K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ryoncil: ODAC/FDA Meeting Discussion
|
|
sailnyssa
|
2.0K |
693K |
10 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
2.0K
|
693K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Ryoncil: ODAC/FDA Meeting Discussion
|
|
sailnyssa
|
2.0K |
693K |
0 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
2.0K
|
693K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ryoncil: ODAC/FDA Meeting Discussion
|
|
sailnyssa
|
2.0K |
693K |
7 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
2.0K
|
693K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ryoncil: ODAC/FDA Meeting Discussion
|
|
sailnyssa
|
2.0K |
693K |
8 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
2.0K
|
693K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
sailnyssa
|
13K |
5.0M |
2 |
13/08/20 |
13/08/20 |
ASX - By Stock
|
13K
|
5.0M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
sailnyssa
|
13K |
5.0M |
45 |
13/08/20 |
13/08/20 |
ASX - By Stock
|
13K
|
5.0M
|
45
|
|
ASX - By Stock
|
MSB |
Re:
FDA ODAC Meeting Material discussion analysis
|
|
sailnyssa
|
491 |
193K |
53 |
13/08/20 |
13/08/20 |
ASX - By Stock
|
491
|
193K
|
53
|
|
ASX - By Stock
|
MSB |
Re:
FDA ODAC Meeting Material discussion analysis
|
|
sailnyssa
|
491 |
193K |
22 |
13/08/20 |
13/08/20 |
ASX - By Stock
|
491
|
193K
|
22
|
|
ASX - By Stock
|
MSB |
Re:
FDA ODAC Meeting Material discussion analysis
|
|
sailnyssa
|
491 |
193K |
18 |
13/08/20 |
13/08/20 |
ASX - By Stock
|
491
|
193K
|
18
|
|
ASX - By Stock
|
MSB |
Re:
FDA ODAC Meeting Material discussion analysis
|
|
sailnyssa
|
491 |
193K |
5 |
13/08/20 |
13/08/20 |
ASX - By Stock
|
491
|
193K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
FDA ODAC Meeting Material discussion analysis
|
|
sailnyssa
|
491 |
193K |
25 |
12/08/20 |
12/08/20 |
ASX - By Stock
|
491
|
193K
|
25
|
|
ASX - By Stock
|
MSB |
Re:
FDA ODAC Meeting Material discussion analysis
|
|
sailnyssa
|
491 |
193K |
2 |
12/08/20 |
12/08/20 |
ASX - By Stock
|
491
|
193K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
FDA ODAC Meeting Material discussion analysis
|
|
sailnyssa
|
491 |
193K |
14 |
12/08/20 |
12/08/20 |
ASX - By Stock
|
491
|
193K
|
14
|
|
ASX - By Stock
|
MSB |
Re:
FDA ODAC Meeting Material discussion analysis
|
|
sailnyssa
|
491 |
193K |
5 |
12/08/20 |
12/08/20 |
ASX - By Stock
|
491
|
193K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
FDA ODAC Meeting Material discussion analysis
|
|
sailnyssa
|
491 |
193K |
30 |
12/08/20 |
12/08/20 |
ASX - By Stock
|
491
|
193K
|
30
|
|
ASX - By Stock
|
MSB |
Re:
Much more risk than reward on the coming Friday
|
|
sailnyssa
|
96 |
38K |
7 |
11/08/20 |
11/08/20 |
ASX - By Stock
|
96
|
38K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading - Aug 2020 on
|
|
sailnyssa
|
2.3K |
906K |
35 |
11/08/20 |
11/08/20 |
ASX - By Stock
|
2.3K
|
906K
|
35
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L
|
|
sailnyssa
|
854 |
431K |
19 |
11/08/20 |
11/08/20 |
ASX - By Stock
|
854
|
431K
|
19
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L
|
|
sailnyssa
|
854 |
431K |
43 |
11/08/20 |
11/08/20 |
ASX - By Stock
|
854
|
431K
|
43
|
|
ASX - By Stock
|
MSB |
Re:
COVID ARDS interim analysis
|
|
sailnyssa
|
37 |
20K |
5 |
10/08/20 |
10/08/20 |
ASX - By Stock
|
37
|
20K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
COVID ARDS interim analysis
|
|
sailnyssa
|
37 |
20K |
14 |
10/08/20 |
10/08/20 |
ASX - By Stock
|
37
|
20K
|
14
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading - Aug 2020 on
|
|
sailnyssa
|
2.3K |
906K |
1 |
10/08/20 |
10/08/20 |
ASX - By Stock
|
2.3K
|
906K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading - Aug 2020 on
|
|
sailnyssa
|
2.3K |
906K |
2 |
10/08/20 |
10/08/20 |
ASX - By Stock
|
2.3K
|
906K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading - Aug 2020 on
|
|
sailnyssa
|
2.3K |
906K |
15 |
10/08/20 |
10/08/20 |
ASX - By Stock
|
2.3K
|
906K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L
|
|
sailnyssa
|
854 |
431K |
6 |
10/08/20 |
10/08/20 |
ASX - By Stock
|
854
|
431K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L
|
|
sailnyssa
|
854 |
431K |
12 |
10/08/20 |
10/08/20 |
ASX - By Stock
|
854
|
431K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L
|
|
sailnyssa
|
854 |
431K |
14 |
10/08/20 |
10/08/20 |
ASX - By Stock
|
854
|
431K
|
14
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L
|
|
sailnyssa
|
854 |
431K |
2 |
10/08/20 |
10/08/20 |
ASX - By Stock
|
854
|
431K
|
2
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
sailnyssa
|
23K |
13M |
11 |
05/08/20 |
05/08/20 |
ASX - By Stock
|
23K
|
13M
|
11
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
sailnyssa
|
23K |
13M |
0 |
03/08/20 |
03/08/20 |
ASX - By Stock
|
23K
|
13M
|
0
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
sailnyssa
|
23K |
13M |
4 |
03/08/20 |
03/08/20 |
ASX - By Stock
|
23K
|
13M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID-19/GVHD Update, Quarterly Report and Appendix 4C
|
|
sailnyssa
|
248 |
94K |
33 |
31/07/20 |
31/07/20 |
ASX - By Stock
|
248
|
94K
|
33
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID-19/GVHD Update, Quarterly Report and Appendix 4C
|
|
sailnyssa
|
248 |
94K |
3 |
30/07/20 |
30/07/20 |
ASX - By Stock
|
248
|
94K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID-19/GVHD Update, Quarterly Report and Appendix 4C
|
|
sailnyssa
|
248 |
94K |
17 |
30/07/20 |
30/07/20 |
ASX - By Stock
|
248
|
94K
|
17
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
sailnyssa
|
17K |
6.8M |
10 |
30/07/20 |
30/07/20 |
ASX - By Stock
|
17K
|
6.8M
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID-19/GVHD Update, Quarterly Report and Appendix 4C
|
|
sailnyssa
|
248 |
94K |
3 |
30/07/20 |
30/07/20 |
ASX - By Stock
|
248
|
94K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
sailnyssa
|
17K |
6.8M |
29 |
30/07/20 |
30/07/20 |
ASX - By Stock
|
17K
|
6.8M
|
29
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
sailnyssa
|
17K |
6.8M |
11 |
30/07/20 |
30/07/20 |
ASX - By Stock
|
17K
|
6.8M
|
11
|
|